Latest Articles

In this feature article, Tanaaz Khan explores the "lingering" promise of lab-based, or "cultured" meat. Does it deliver on its promise of being a greener and more ethical alternative to meat?

This article will discuss the challenges associated with cryopreservation and recent developments in the field.

In this article, we will describe what benign and malignant tumors are, explore the similarities and differences between the two types of tumors and discuss if benign tumors can become malignant.

Dr. Alexandra Freeman believes that the major problems associated with research culture in science can be traced back to one source: the current scientific publishing model. In this interview with Technology Networks, she explains why a novel approach, called Octopus, is a logical solution to these issues.

This article explores the world of organoids, their benefits and limitations, and where they may play a role in the future of disease modeling.

To mark World Breastfeeding Week 2022, Technology Networks interviewed Dr. Alecia-Jane Twigger. Dr. Twigger is a postdoctoral researcher at the University of Cambridge, where her research focuses on understanding how factors such as pregnancy and lactation influence mammary gland biology, and breast cancer risk.

In this article, we discuss key challenges in vaccine development scale up, highlighting various strategies for overcoming them.

To learn more about the link between endocannabinoids and ASD and how innovative models are helping to study the ECS and its effects on the developing brain, Technology Networks spoke to Drs. Karen Litwa and Ken Soderstrom from East Carolina University.

In this article, we will cover the basics, strengths and limitations and applications of traditional and emerging neuroimaging techniques, and discuss the prospects, challenges, risks and ethics concerned with this rapidly expanding field.

Angiogenesis is the growth of new blood vessels. However, this process is often dysregulated in cancer. In this article, we will describe what angiogenesis is, how it goes out of control in cancer and how drugs can target it to inhibit tumor growth.